Peptides targeting the BTLA-HVEM complex can modulate T cell immune response

Area of Science:

• Immunology
• Molecular Biology

Background:

• Immune checkpoints regulate T cell responses.
• The BTLA-HVEM complex is crucial for maintaining T cell responsiveness.
• Dysregulation of immune checkpoints can impair immune function.

Purpose of the Study:

• To investigate the immunomodulatory potential of five novel peptides targeting the BTLA-HVEM complex.
• To assess the effects of these peptides on human T cell activity, including activation, proliferation, and memory compartment changes.

Main Methods:

• Human T cells were isolated and treated with peptides alone or with CD3/CD28 monoclonal antibodies (mAbs).
• Flow cytometry was employed to analyze T cell activation markers (CD69, CD62L, CD25), memory phenotype, proliferation, and apoptosis.
• Experiments were conducted over 72-hour and 120-hour periods.

Main Results:

• Peptides demonstrated immunomodulatory effects on T cells.
• An increase in CD4+ and CD8+ T cells expressing activation markers (CD69, CD25) was observed.
• Enhanced T cell proliferation and alterations in the T cell memory compartment were noted.
• Peptides Pep(2) and Pep(5) exhibited the most significant immune-restoring potential.

Conclusions:

• The studied peptides, particularly Pep(2) and Pep(5), can modulate human T cell activity.
• These peptides hold promise for restoring immune function by targeting the BTLA-HVEM pathway.
• Further research into these peptides could lead to novel immunotherapeutic strategies.